Chengdu Jiabao Pharmaceutical Silver Pharmaceutical Technology

Chengdu Jiabao Pharmaceutical and Chengdu Yinhe Pharmaceutical Technology are core subsidiaries of the Sichuan Kelun Pharmaceutical Group, based in Chengdu, China. Chengdu Jiabao operates as a major manufacturing hub for chemical drugs and active pharmaceutical ingredients (APIs), while Chengdu Yinhe (frequently translated as Silver Pharmaceutical Technology) serves as a critical R&D center for innovative drug discovery. These entities are central to Kelun's strategic evolution from a leader in intravenous infusions to a research-driven biopharmaceutical powerhouse. They support a robust pipeline of advanced therapies, including antibody-drug conjugates (ADCs) and immunotherapies, often in collaboration with Kelun-Biotech and international partners such as Merck & Co. (MSD).